Colon cancer is the third most commonly diagnosed cancer in the United States. Recent reports 35 have shown that the location of the primary tumor is of clinical importance. Patients with right-36 sided cancers (RCCs) (tumors arising between the cecum and proximal transverse colon) have 37 poorer clinical outcomes than those with left-sided colon cancers (LCCs) (tumors arising 38 between the distal transverse colon and sigmoid colon, excluding the rectum). Interestingly, 39 women have a lower incidence of colon cancer than men do. However, women have a higher 40 propensity for RCC than men. Identification of gene expression differences between RCC and 41 LCC is considered a potential means of prognostication. Furthermore, studying colon cancer 42 sidedness could reveal important predictive markers for response to various treatments. This 43 study provides a comprehensive bioinformatic analysis of various genes and molecular 44 pathways that correlated with sex and anatomical location of colon cancer using four publicly 45 available annotated datasets housed in the National Center for Biotechnology Information's 46 Gene Expression Omnibus (GEO). We identified differentially expressed genes in tumor 47 tissues from women with RCC, which showed attenuated energy and nutrient metabolism when 48 compared to women with LCC. Specifically, we showed that the downregulation of 5' AMP-49 activated protein kinase alpha subunit (AMPKα) and downregulated anti-tumor immune 50 response in women with RCC. This difference was not seen when comparing tumor tissues 51 from men with RCC to men with LCC. Therefore, women with RCC may have a specific 52 metabolic and immune phenotype which accounts for differences in prognosis and treatment 53 response. 54 55
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which also have roles in decreasing sirtuin 6 expression and indicates decreased activation of 277 FOXO3A by SIRT1. Interestingly, SIRT1 has been implicated in the regulation of cancer cell 278 proliferation through regulation of sex steroid hormones (Moore et al., 2012) . 279 The enrichment of the carbohydrate-responsive element-binding protein (ChREBP) 280 pathway points again to changes in nutrient supply. ChREBP is inhibited by cAMP and PKA, 281 here we observed that PKA-cat is activated (due to downregulation of PKA-reg), which would 282 decrease phosphorylation and activation of ChREBP. We also observed that AMPKα is 283 significantly downregulated along with acyl-coenzyme A synthetase (ACS) ( Figure 5 ), which 284 would conversely cause ChREBP activation. Deregulation of these genes as a response to 285 nutrient supply suggests a role for ChREBP-mediated glucose and fatty acid metabolic control 286 and may play a role in cell proliferation. The mammalian target of rapamycin complex 1 287 (mTORC1) signaling pathway was also enriched ( Figure 6 ) suggesting a nutrient deplete 288 environment in women with RCC. Tubulin tyrosine ligase 1 (TTL1) and AMPKα were both 289 downregulated in women with RCC. mTOR regulation is known to play a role in colon cancer 290 biology (Kimmelman and White, 2017).
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The ATP metabolic pathway was found to be significantly altered ( Figure 7) . PDE3A 292 and ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) were downregulated, 293 whereas pyruvate kinase muscle isozyme M2 (PKM2) and PDE10A were upregulated.
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Downregulation of ENPP1 and PDE3A indicates decreased breakdown of ATP and cAMP 295 respectively, to generate AMP, also increased PKM2 indicates increased ATP production from 296 the metabolism of phosphoenolpyruvate and ADP to pyruvate. Therefore, this pathway also 297 substantiates widespread disruption to AMP and ATP generation.
298
One other distinct mechanism showing significant enrichment in RCC compared to 299 LCCs in women was antigen presentation by major histocompatibility complex class I ( Figure   300 8). All the genes from our datasets that were linked through this pathway were upregulated, 301 suggesting an increase in activity in this pathway; heat shock protein (HSP)70, hypoxia up-302 regulated protein 1 (HYOU1), and CHIP partake in antigen endocytosis, antigen presentation, 303 and T-cell immune response. Of note, the protein encoded by HYOU1 belongs to the HSP70 304 family, which has been shown to be related to cell growth and cancer progression (Jagadish et 305 al., 2016). Interestingly, HSP105, a member of the HSP70 family that has been shown to play 
